(19)
(11) EP 2 316 430 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
11.07.2012 Bulletin 2012/28

(45) Mention of the grant of the patent:
06.06.2012 Bulletin 2012/23

(21) Application number: 10182198.1

(22) Date of filing: 07.10.2005
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)

(54)

Controlled release pharmaceutical compositions comprising a fumaric acid ester

Pharmazeutische Zusammensetzung zur kontrollierten Freisetzung eines Fumarsäureesters

Composition pharmaceutique pour la libération controllée d'une ester d'acide fumarique

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 08.10.2004 DK 200401546
10.11.2004 DK 200401736
11.02.2005 DK 200500211
23.03.2005 DK 200500419
16.06.2005 US 691513 P

(43) Date of publication of application:
04.05.2011 Bulletin 2011/18

(62) Application number of the earlier application in accordance with Art. 76 EPC:
05789026.1 / 1799196

(73) Proprietor: Forward Pharma A/S
1100 Copenhagen K (DK)

(72) Inventors:
  • Nilsson, Henrik
    1030 Wien (AT)
  • Schönharting, Florian
    1100 Koebenhavn K. (DK)
  • Müller, Bernd W
    24220 Flintbek (DE)
  • Robinson, Joseph R.
    Madison, Wisconsin 53719 (US)

(74) Representative: HOFFMANN EITLE 
Patent- und Rechtsanwälte Arabellastraße 4
81925 München
81925 München (DE)


(56) References cited: : 
US-A- 4 959 389
US-A1- 2003 013 761
US-B1- 6 359 003
 US-A- 5 424 332
US-B1- 6 355 676
   
  • KREUTER A ET AL: "TREATMENT OF DISSEMINATED GRANULOMA ANNULARE WITH FUMARIC ACID ESTERS", BMC DERMATOLOGY, BIOMED CENTRAL,, US, vol. 2, no. 5, 19 March 2002 (2002-03-19), XP008047020, ISSN: 1471-5945
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).